Isbn: 9783389179758 - red biotechnology between innovation and ethics. human embryo editing (4 risultati)

Perfeziona la tua ricerca

  • Libri (4)

  • Nuovo (4)

a

Fascia di prezzo personalizzata (EUR)

a

  • Lingua: Inglese

    Editore: GRIN Verlag, 2026

    3389179755 / 9783389179758

    • Brossura

    Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 19,95

    EUR 35,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibile

    Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Seminar paper from the year 2025 in the subject Economics - Innovation economics, grade: 1,0, University of Hohenheim (Economics), course: Master Seminar in Innovation Economics, language: English, abstract: Red biotechnology, often described as medical biotechnology, represents one of the most transformative areas of modern science and healthcare. It encompasses the development of biopharmaceuticals, gene therapies, and personalized medicine strategies that are reshaping treatment approaches for numerous diseases. This seminar paper aims to examine the relationship of ethical public concerns and their influence on innovation in these fields The global biotechnology sector has experienced rapid growth, driven by advances in molecular biology, genetic engineering, and bioinformatics. Despite its enormous potential, red biotechnology also faces considerable challenges such as high research and development costs, ethical and regulatory complexity, and unequal access to advanced therapies.This paper also aims to examine whether there's a correlation between the ethical acceptance of human embryo genome editing, trust in regulatory institutions, and the benefit perception. This relationship is investigated among 109 medicine students at the University of Ulm through a quantitative survey. Core questions in the survey were whether they are willing to use techniques of gene editing and especially gene editing of embryos. This was tested under different risk factors. Finally, all participants were asked an open question about what they perceive as the biggest problem with human embryo gene editing.…

  • Lingua: Inglese

    Editore: GRIN Verlag, GRIN Verlag Jan 2026, 2026

    3389179755 / 9783389179758

    • Brossura
    • Print on Demand

    Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 19,95

    EUR 23,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 2 disponibili

    Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 36 pp. Englisch.

  • Lingua: Inglese

    Editore: GRIN Verlag, GRIN Verlag Jan 2026, 2026

    3389179755 / 9783389179758

    • Brossura
    • Print on Demand

    Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 19,95

    EUR 60,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 1 disponibile

    Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Seminar paper from the year 2025 in the subject Economics - Innovation economics, grade: 1,0, University of Hohenheim (Economics), course: Master Seminar in Innovation Economics, language: English, abstract: Red biotechnology, often described as medical biotechnology, represents one of the most transformative areas of modern science and healthcare. It encompasses the development of biopharmaceuticals, gene therapies, and personalized medicine strategies that are reshaping treatment approaches for numerous diseases. This seminar paper aims to examine the relationship of ethical public concerns and their influence on innovation in these fields The global biotechnology sector has experienced rapid growth, driven by advances in molecular biology, genetic engineering, and bioinformatics. Despite its enormous potential, red biotechnology also faces considerable challenges such as high research and development costs, ethical and regulatory complexity, and unequal access to advanced therapies.This paper also aims to examine whether there's a correlation between the ethical acceptance of human embryo genome editing, trust in regulatory institutions, and the benefit perception. This relationship is investigated among 109 medicine students at the University of Ulm through a quantitative survey. Core questions in the survey were whether they are willing to use techniques of gene editing and especially gene editing of embryos. This was tested under different risk factors. Finally, all participants were asked an open question about what they perceive as the biggest problem with human embryo gene editing.Books on Demand GmbH, Überseering 33, 22297 Hamburg 36 pp. Englisch. …

  • Lingua: Inglese

    Editore: GRIN Verlag, 2026

    3389179755 / 9783389179758

    • Brossura
    • Print on Demand

    Da: preigu, Osnabrück, Germaniapreigu

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 19,95

    EUR 70,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 5 disponibili

    Taschenbuch. Condizione: Neu. Red Biotechnology Between Innovation and Ethics. Human Embryo Editing | Tessa Weider | Taschenbuch | Englisch | 2026 | GRIN Verlag | EAN 9783389179758 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand. …